# Molecular pathways affected by drugs that disrupt Na+ and lipid homeostasis in malaria parasites > **NIH NIH R01** · DREXEL UNIVERSITY · 2024 · $686,225 ## Abstract Project Summary In recent years, several chemically diverse compounds have been identified that target PfATP4, a P-type ATPase involved in maintaining Na+ homeostasis in malaria parasites. Some of these compounds have advanced to clinical trials. Thus, PfATP4-active compounds are among the most attractive new antimalarials being developed to counter the continuing threat of drug resistance. Over the previous funding period, we have discovered some dramatic alterations in parasite physiology that accompany a short 2 h exposure to PfATP4 inhibitors. These include: i) Rapid alterations in lipid homeostasis within the parasites with reversible accumulation of cholesterol in the parasite plasma membrane (PPM); ii) Morphological changes resembling premature schizogony; and iii) Massive dephosphorylation of parasite proteins that may underlie the metabolic slowdown that follows PfATP4 inhibition. These observations reveal a collection of hitherto unknown interrelated molecular pathways, disruptions of which result in parasite demise. We found that PfATP4 inhibition appears to result in inhibition of PfNCR1, another druggable transporter, that is involved in maintaining lipid/cholesterol homeostasis within the PPM. Reduction of cholesterol content of the RBC plasma membrane results in dramatic expulsion of trophozoites from the host cell without the lysis of the RBC membrane. Remarkably, treatment with either PfATP4 or PfNCR1 inhibitors prevents this expulsion. These studies suggest an active transport of cholesterol between the RBC plasma membrane and the parasite. We found that trophozoite stage parasites exposed to PfATP4 inhibitors for just 2 h undergo massive morphological changes that resemble premature onset of schizogony events including the formation of inner membrane complexes, rhoptry-like structures and karyokinesis. In addition, trophozoites undergo massive reduction of a large number of metabolites suggestive of metabolic shutdown. We hypothesize that underlying all these events is a signaling cascade unleashed by the influx of Na+ into parasite cytoplasm following PfATP4 inhibition. In support of this proposition, we found dephosphorylation of a large number of proteins, prominent among which were molecules involved in DNA metabolism, chromosome segregation and cell cycle processes. The complexity of events triggered by PfATP4 inhibition requires a multidisciplinary approach. For this purpose, we have recruited outstanding co-investigators in consortium arrangements for the next funding period. Together, we propose to carry out the following specific aims: i) Investigate the relationship between cholesterol dynamics and its role in fatty acid and lipid transport in P. falciparum; ii) Explore the significance of dephosphorylation of proteins that follows PfATP4 inhibition; iii) Examine the causes of metabolic slowdown following PfATP4 inhibition; iv) Derive structural information for PfATP4 and PfNCR1 to understand molecular details about t... ## Key facts - **NIH application ID:** 10764317 - **Project number:** 5R01AI132508-07 - **Recipient organization:** DREXEL UNIVERSITY - **Principal Investigator:** AKHIL B VAIDYA - **Activity code:** R01 (R01, R21, SBIR, etc.) - **Funding institute:** NIH - **Fiscal year:** 2024 - **Award amount:** $686,225 - **Award type:** 5 - **Project period:** 2017-05-05 → 2027-12-31 ## Primary source NIH RePORTER: https://reporter.nih.gov/project-details/10764317 ## Citation > US National Institutes of Health, RePORTER application 10764317, Molecular pathways affected by drugs that disrupt Na+ and lipid homeostasis in malaria parasites (5R01AI132508-07). Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/grant/nih/10764317. Licensed CC0. --- *[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*